The Brendan Wood TopGun Index ETF (BWTG) seeks to track the Brendan Wood TopGun Index, which measures the performance of companies identified through Brendan Wood's proprietary research methodology that analyzes institutional investor sentiment and corporate management quality rankings. This equity-focused strategy targets firms receiving highest ratings from institutional money managers.
How It Works
BWTG uses a rules-based approach that selects stocks based on Brendan Wood International's qualitative research surveys of institutional investors who rate corporate management teams on strategic vision, execution capability, and investor relations effectiveness. The fund employs a modified market-cap weighting methodology, concentrating holdings in companies that receive 'TopGun' designations from surveyed institutional investors. Rebalancing occurs semi-annually to reflect updated management quality rankings and maintain alignment with the proprietary index methodology.
Key Features
- Unique selection methodology based on institutional investor surveys rating corporate management quality rather than traditional financial metrics
- Zero expense ratio structure makes it one of the lowest-cost actively-managed equity strategies available to retail investors
- Recently launched fund with limited performance history but novel approach to identifying high-quality management teams
Risks
- This ETF can lose value if the proprietary management quality methodology fails to identify outperforming companies or if highly-rated management teams underperform market expectations
- Concentration risk exists as the fund may hold fewer positions than broad market ETFs, potentially amplifying individual stock volatility impacts
- New fund launch risk means no established track record to evaluate strategy effectiveness during various market cycles or economic conditions
Who Should Own This
Best suited for sophisticated investors with high risk tolerance and 3-5 year time horizons seeking alternative factor exposure through management quality screening. Appropriate as a satellite holding representing 5-15% of equity allocation for investors interested in novel selection methodologies. Requires patience given the fund's recent inception and unproven strategy performance.